RE:RE:Get ready for more merger mania in the pharma sector This simple observation requires further emphasis - “Pfizer’s move put boards across big pharma on notice that if you’re not in the market buying these companies while they’re cheap, your competitors will,” Thomas Hayes, chairman and managing member of Great Hill Capital in New York, said.